Summary
This international multicentre study, as suggested by the large author consortium and journal scope, examined whether the molecular heterogeneity of muscle-invasive bladder cancer differs between sexes. The work contributes to understanding sex-driven variation in bladder cancer biology, which may have implications for precision oncology and treatment stratification. No abstract was available to confirm specific molecular classifications or clinical endpoints studied.
UK applicability
Findings on sex-specific molecular subtypes in bladder cancer would be relevant to UK oncology practice and treatment guidelines if validated in UK cohorts; however, direct applicability depends on whether the study included UK centres and whether molecular subtyping is adopted in routine NHS practice.
Key measures
Molecular subtype classification and distribution stratified by sex; potentially clinicopathological features and outcome associations by subtype and sex
Outcomes reported
The study examined the distribution of molecular subtypes of muscle-invasive bladder cancer across sex groups, as suggested by the title. Findings likely characterised differences in cancer subtype prevalence or biological features between male and female patients.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.